ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
Dow Jones
43,487.83
0.78%
Brent Oil
80.005
0.00%
Bitcoin
104,797.59
0.36%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Simpar S.A. (SIMH3) Quote

Simpar S.A.

Simpar S.A. (SIMH3)

BOV
3.31
-0.03
(-0.90%)
Closed January 19 3:55PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.30
Bid
3.28
Ask
3.39
Volume
3,778,500
3.27 Day's Range 3.41
3.21 52 Week Range 8.93
Market Cap
2.881B
Previous Close
3.34
Open
3.37
Last Trade
400
@
3.3
Last Trade Time
Financial Volume
R$ 12,639,083
VWAP
3.345
Average Volume (3m)
4,738,033
Shares Outstanding
873,040,533
Dividend Yield
-
PE Ratio
-5.82
Earnings Per Share (EPS)
-0.57
Revenue
33.11B
Net Profit
-495.22M

About Simpar S.A.

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Website
ri.simpar.com.br
Headquarters
Sao Paulo, Sao Paulo, Bra
Founded
-
Simpar S.A. is listed in the Offices-holdng Companies sector of the Brazil Bovespa Exchange with ticker SIMH3. The last closing price for Simpar ON was R$3.34. Over the last year, Simpar ON shares have traded in a share price range of R$ 3.21 to R$ 8.93.

Simpar ON currently has 873,040,533 shares outstanding. The market capitalization of Simpar ON is R$2.92 billion. Simpar ON has a price to earnings ratio (PE ratio) of -5.82.

Ask ADVFN Intelligence (AI)

SIMH3 Latest News

More News

JSL has been included in the 2015 ISE portfolio

JSL has been included in the 2015 ISE portfolio PR Newswire MOGI DAS CRUZES, Brazil, Nov. 26, 2014 MOGI DAS CRUZES, Brazil, Nov. 26, 2014 /PRNewswire/ -- JSL (BM&FBOVESPA: JSLG3 and OTC:...

November 26 2014
PR Newswire (US)

JSL announces its 2Q14 Results - Record Total Net Revenue of R$ 1.415 billion (+21.4%) and Record of Consolidated EBITDA(2) o...

JSL announces its 2Q14 Results - Record Total Net Revenue of R$ 1.415 billion (+21.4%) and Record of Consolidated EBITDA(2) of R$ 214.0 million (+26.0%) PR Newswire MOGI DAS CRUZES, Brazil, July...

July 28 2014
PR Newswire (US)

JSL - Total Gross Revenue grows 20% and Gross Revenue from Services grows 11% in 2Q14

JSL - Total Gross Revenue grows 20% and Gross Revenue from Services grows 11% in 2Q14 PR Newswire MOGI DAS CRUZES, Brazil, July 21, 2014 MOGI DAS CRUZES, Brazil, July 21, 2014 /PRNewswire/ -- JSL...

July 21 2014
PR Newswire (US)

JSL estimates an increase between 12% and 16% in gross revenue from services in 2014 versus 2013

JSL estimates an increase between 12% and 16% in gross revenue from services in 2014 versus 2013 PR Newswire MOGI DAS CRUZES, Brazil, April 25, 2014 MOGI DAS CRUZES, Brazil, April 25, 2014...

April 25 2014
PR Newswire (US)

JSL announces its 1Q14 Results - Gross Revenue from Service (Logistica + Movida) of R$ 946.0 million (+11.5%) and EBITDA² (L...

JSL announces its 1Q14 Results - Gross Revenue from Service (Logistica + Movida) of R$ 946.0 million (+11.5%) and EBITDA² (Logística + Movida) of R$ 180.1 million (+9.2%) PR Newswire MOGI DAS...

April 25 2014
PR Newswire (US)

JSL - R$ 2.4 billion in new contracts in 2013

JSL - R$ 2.4 billion in new contracts in 2013 PR Newswire MOGI DAS CRUZES, Brazil, March 28, 2014 MOGI DAS CRUZES, Brazil, March 28, 2014  /PRNewswire/ --JSL (BM&FBOVESPA: JSLG3 and ADR Level...

March 28 2014
PR Newswire (US)

JSL S.A. Webcast Presentation from the Deutsche Bank Depositary Receipts Virtual Investor Conference Now Available for On-dem...

JSL S.A. Webcast Presentation from the Deutsche Bank Depositary Receipts Virtual Investor Conference Now Available for On-demand Viewing: Company invites individual and institutional investors to...

November 29 2013
PR Newswire (US)

JSL S.A. to Present at the November 14 Deutsche Bank Depositary Receipts Virtual Investor Conference

JSL S.A. to Present at the November 14 Deutsche Bank Depositary Receipts Virtual Investor Conference Company invites individual retail investors, institutional investors and analysts to attend...

November 06 2013
PR Newswire (US)

International Companies to Host Live Webcasts at Deutsche Bank's November 14 Depositary Receipts Virtual Investor Conference

International Companies to Host Live Webcasts at Deutsche Bank's November 14 Depositary Receipts Virtual Investor Conference PR Newswire NEW YORK, Oct. 31, 2013 NEW YORK, Oct. 31, 2013...

October 31 2013
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.13-3.790087463563.433.533.2147932803.36413216CS
4-0.01-0.3021148036253.313.83.2142022193.47699764CS
12-2.16-39.56043956045.465.753.2147380334.24755569CS
26-3.52-51.61290322586.827.153.2141617365.09638281CS
52-5.5-62.58.88.933.2139568045.8353779CS
156-6.05-64.70588235299.3512.873.2134509177.72037845CS
260-4.6725-58.60771401697.972517.88752.387525803628.15807259CS

SIMH3 - Frequently Asked Questions (FAQ)

What is the current Simpar ON share price?
The current share price of Simpar ON is R$ 3.30
How many Simpar ON shares are in issue?
Simpar ON has 873,040,533 shares in issue
What is the market cap of Simpar ON?
The market capitalisation of Simpar ON is BRL 2.92B
What is the 1 year trading range for Simpar ON share price?
Simpar ON has traded in the range of R$ 3.21 to R$ 8.93 during the past year
What is the PE ratio of Simpar ON?
The price to earnings ratio of Simpar ON is -5.82
What is the cash to sales ratio of Simpar ON?
The cash to sales ratio of Simpar ON is 0.09
What is the reporting currency for Simpar ON?
Simpar ON reports financial results in BRL
What is the latest annual turnover for Simpar ON?
The latest annual turnover of Simpar ON is BRL 33.11B
What is the latest annual profit for Simpar ON?
The latest annual profit of Simpar ON is BRL -495.22M
What is the registered address of Simpar ON?
The registered address for Simpar ON is RUA RENATO PAES DE BARROS N. 1017 10�� ANDAR, CONJUNTO 101, SAO PAULO, SAO PAULO, 04530001
What is the Simpar ON website address?
The website address for Simpar ON is ri.simpar.com.br
Which industry sector does Simpar ON operate in?
Simpar ON operates in the OFFICES-HOLDNG COMPANIES,NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AGXY3Agrogalaxy Participacoes SA
R$ 0.72
(63.64%)
3.38M
CGAS3Cia Gas Sao Paulo Comgas
R$ 158.97
(30.10%)
300
SEQL3Sequoia Logistica e Transportes SA
R$ 3.32
(13.31%)
1.58M
AMAR11Lojas Marisa S.A.
R$ 0.57
(9.62%)
20.2k
FICT3Fictor Alimentos S.A.
R$ 3.28
(9.33%)
83k
DASA11Diagnosticos da America S.A
R$ 0.70
(-22.22%)
500
BIOM11Biomm SA
R$ 0.99
(-17.50%)
1.5k
ESTR4Manufatura Brinquedos Estrela Sa
R$ 3.56
(-11.00%)
1.5k
NORD3Nordon Inds Metalurgicas Sa
R$ 6.10
(-7.58%)
700
YDUQ3YDUQS Participacoes S.A.
R$ 8.58
(-5.71%)
12.55M
BBDC4Bco Bradesco Sa
R$ 11.59
(-1.19%)
60.74M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.24
(-5.49%)
58.19M
VALE3Vale SA
R$ 54.49
(3.46%)
54.66M
ABEV3Ambev SA
R$ 11.09
(0.09%)
51.43M
COGN3CognaEducacao SA
R$ 1.25
(1.63%)
41.06M

Discussion

View Full Feed
NomadAstronaut241 NomadAstronaut241 2 minutes ago
Does the guy run this out of his garage?
ZENA
LakeshoreLeo1953 LakeshoreLeo1953 3 minutes ago
I’ll give you the Tigers and raise you the Lions!!!
We’ll see how the former Lion likes a snowball Philly fan base.
AVXL
Laster Laster 3 minutes ago
Huge gap at $15. Space stocks out of favor right now. Spacex failure doesn’t help.
No Mars contract. Likely financing announcement in the next few months.
50-day MA at $22.50 and 200 day MA at $18.
Support line at around $20.
I think this stock will do well long term but
RKLB
Monksdream Monksdream 4 minutes ago
The good thing is the bottoms are far apart
RIVN
exwannabe exwannabe 4 minutes ago
Extracted from TDD post:
While objective response rate (ORR) was not the primary endpoint, the data does focus on survival as a key metric. The trial did not report significant tumor shrinkage or traditional ORR (complete or partial responses), which may lead some to conclude a "0% ORR" in co
NWBO
PENNY PIRATE PENNY PIRATE 5 minutes ago
It's going to be a Very Happy 2025! “On behalf of the entire AABB team, we are excited and highly anticipate all the corporate events that will be achieved as the new year progresses. We would like to thank our shareholders and everyone following our Company for their continued support of our vision
AABB
Tool_power Tool_power 6 minutes ago
RIVN 1-year chart: It’s a big juicy double bottom that’s getting ready for a breakout.
RIVN
Trooperstocks Trooperstocks 6 minutes ago
TIkTokBan In Effect -TikTok is down

https://investorshub.advfn.com/uimage/uploads/2025/1/19/svqfpWhatsApp_Image_2025-01-18_at_20.55.42_d9f6033c.jpg

(Nasdaq: ILLR)
ILLR
TechSectorPlayer TechSectorPlayer 6 minutes ago
That's Because their is NO reason it is a $5.00 + plus stock. Doesn't have the Revenue, Sales, Orders or Cash Flow. Putting all their reserves into Bit Coin It must be run by Geniuses .... NOT Everyone knows it's going down ......
KULR
XMaster2023 XMaster2023 7 minutes ago
Theory extracting from DD post below is the answer to your question. In short, you don’t understand or comprehend the response or you don’t care to understand the response. You’re looking like a fool.

Extracted from TDD post:
While objective response rate (ORR) was not the pr
NWBO
Trooperstocks Trooperstocks 7 minutes ago
TRILLER is NOW the Top #3 Downloaded App

https://investorshub.advfn.com/uimage/uploads/2025/1/19/ohr[kWhatsApp_Image_2025-01-18_at_23.34.11_dddcd0c6.jpg


(Nasdaq:ILLR)
ILLR
wadegarret wadegarret 8 minutes ago
At some point over the coming months, it will be

prudent to short tech in some form imo.
mick mick 9 minutes ago
NEEDS AN UPDATE;
Picks AH OF INTEREST IN CANCELLED DEAL $MIKP & $SAKL cancelled recently 03-20-2023 /
SHORTING
DEAL CANCELLED
SAKL BUYS 45% INTEREST IN $MIKP
11-12-2022 SOMETHING IS GOING ON WIT
$MIKP & $SAKL
$SAKL BUYING INTEREST OF 45% OF $MIK
AABB AAPT ABUS
Nebuchadnezzar Nebuchadnezzar 10 minutes ago
fyi, the RITE CEO sent out letters and updates to shareholders a few months ago, but you know what the cherry on top was?

he HAND SIGNED the letter, that is class, that is professional and unheard of, especially from any CEO let alone a CEO from a PINK OTC stock

i added
RITE
Clark6290 Clark6290 10 minutes ago
Are you aware this is 2025, not 2008. Just so you know there is no current crisis.
FNMA
splintered sunlight splintered sunlight 11 minutes ago
Ya think??????????????
BBUZ
Sheddoggie Sheddoggie 11 minutes ago
NOBODY is going to lend Henry $12.5 billion.

Henries track record speaks for itself. You can go all the way back 30 years and see that Henry has been trying the same cons since then. That said...I'll buy a few mill as soon as this hits .0001 again. Still plenty of stupid people believ
PHIL
LakeshoreLeo1953 LakeshoreLeo1953 11 minutes ago
I assume from your comment that your area(s) of expertise/experience is in family care?
Does it expand beyond that?
Scientific or Corporate biotech?

Unsure what imprimatur you wish for your input.
AVXL
CaptBeer CaptBeer 11 minutes ago
How's your Italian?
https://www.pharmastar.it/pharmastartv//business/amarin-introduce-in-italia-un-nuovo-farmaco-contro-il-rischio-cardiovascolare-residuo-13781
AMRN
KVM KVM 12 minutes ago
Agree. On a side note is GRRR on your ai radar. Baisicly do same thing as Veri and involved in more. Have a law enforcement platform and involved in smart cities in international markets and just now getting into US market. See my comments on GRRR board
GRRR
jbog jbog 12 minutes ago
Mufasco,

I agree with you that they are in the copy and modification mode, but keep in mind they can do it at a fraction of the cost. U.S and Euro research has become unsustainable considering the monies that are spent. This is why research Bio's have been a group to avoid.
FACT-MASTER FACT-MASTER 12 minutes ago
Let's ROCK!!

https://www.youtube.com/watch?v=_DRNljTgiyg
DJT
mick mick 12 minutes ago
GOOD MORNING
SkyLimit2022 SkyLimit2022 13 minutes ago
suit,

Thanks for asking 😶

Your posts, the ASM recording, and the trial results are there for anyone to read/listen and judge for themselves.

Thanks again for reminding us about the ASM and about the past DCVax Direct clinical study at MD Anderso
ASM

Your Recent History

BOV
SIMH3
Simpar ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads